quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:05:42·867d
NEWSRelease
Aligos Therapeutics Inc. logo
Ault Alliance Inc. logo
Avid Bioservices Inc. logo
+17

Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

ALGS· Aligos Therapeutics Inc.AULT· Ault Alliance Inc.CDMO· Avid Bioservices Inc.CLEU· China Liberal Education Holdings LimitedCLIN· Clean Earth Acquisitions Corp.CYN· Cyngn Inc.
Health CareTechnologyReal Estate
Original source

Companies

  • ALGS
    Aligos Therapeutics Inc.
    Health Care
  • AULT
    Ault Alliance Inc.
    Technology
  • CDMO
    Avid Bioservices Inc.
    Health Care
  • CLEU
    China Liberal Education Holdings Limited
    Real Estate
  • CLIN
    Clean Earth Acquisitions Corp.
    Utilities
  • CYN
    Cyngn Inc.
    Technology
  • FLJ
    FLJ Group Limited
    Finance
  • GDHG
    Golden Heaven Group Holdings Ltd.
    Consumer Discretionary
  • HCP
    HashiCorp Inc.
    Technology
  • HPCO
    Hempacco Co. Inc.
    Health Care
  • MBI
    MBIA Inc.
    Finance
  • MOMO
    Hello Group Inc.
    Technology
  • RH
    RH
    Consumer Discretionary
  • SLDB
    Solid Biosciences Inc.
    Health Care
  • SLS
    SELLAS Life Sciences Group Inc.
    Health Care
  • SNOA
    Sonoma Pharmaceuticals Inc.
    Health Care
  • SVFD
    Save Foods Inc.
    Consumer Staples
  • THAR
    Tharimmune Inc.
    Health Care
  • TRKA
    Troika Media Group Inc.
    Consumer Discretionary
  • XCUR
    Exicure Inc.
    Health Care

Recent analyst ratings

  • Mar 25RHUpdateTelsey Advisory Group$165.00
  • Mar 20SLDBUpdateGuggenheim$26.00
  • Mar 19ALGSUpdateJefferies$48.00
  • Dec 12RHUpdateStifel$165.00
  • Dec 12RHUpdateTelsey Advisory Group$185.00
  • Dec 4SLDBUpdateNeedham$16.00

Related

  • SEC13h
    SEC Form DEFA14A filed by SELLAS Life Sciences Group Inc.
  • SEC13h
    SEC Form DEF 14A filed by SELLAS Life Sciences Group Inc.
  • SEC13h
    SEC Form DEFA14A filed by Solid Biosciences Inc.
  • SEC13h
    SEC Form DEF 14A filed by Solid Biosciences Inc.
  • SEC1d
    Amendment: SEC Form S-1/A filed by Sonoma Pharmaceuticals Inc.
  • PR1d
    Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
  • SEC1d
    SEC Form SCHEDULE 13G filed by Cyngn Inc.
  • SEC2d
    SEC Form 8-K filed by Aligos Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022